(Q54792878)

3 June 2018

title

End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. (English)

1 reference

3 June 2018

0 references

1

1 reference

3 June 2018

author name string

Vera Pravica

2

1 reference

3 June 2018

Philip J Geraghty

3

1 reference

3 June 2018

Maurice Super

4

1 reference

3 June 2018

A Kevin Webb

5

1 reference

3 June 2018

Martin Schwarz

6

1 reference

3 June 2018

Ian V Hutchinson

7

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 February 2003

1 reference

3 June 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

3 June 2018

volume

167

1 reference

3 June 2018

issue

3

1 reference

3 June 2018

page(s)

384-389

1 reference

3 June 2018

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Normal splenic size in infants and children: sonographic measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Phenotype of CF and the effects of possible modifier genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Variable Severity of Pulmonary Disease in Adults with Identical Cystic Fibrosis Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Correlation between genotype and phenotype in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Lung cytokine production in bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Human endothelial cells are activated by interferon-gamma plus tumour necrosis factor-alpha to kill intracellular Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Variation at the Angiotensin-converting enzyme and endothelial nitric oxide synthase genes is associated with the risk of esophageal varices among patients with alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200204-364OC

10.1164/RCCM.200204-364OC

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

12554626

1 reference

3 June 2018